{
  "title": "Cancer Monoclonal Antibodies Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)",
  "slug": "cancer-monoclonal-antibodies-market",
  "industry": "Pharmaceuticals & Therapeutics",
  "parent_industry": "Healthcare (Pharma, Medical Devices, Biotech)",
  "url": "https://www.mordorintelligence.com/industry-reports/cancer-monoclonal-antibodies-market",
  "scraped_at": "2026-09-17T17:43:43+07:00",
  "dataset_properties": [
    {
      "@type": "PropertyValue",
      "name": "Market Size (2026)",
      "value": 107.82,
      "unitText": "USD Billion"
    },
    {
      "@type": "PropertyValue",
      "name": "Market Size (2031)",
      "value": 227.16,
      "unitText": "USD Billion"
    },
    {
      "@type": "PropertyValue",
      "name": "Growth Rate (2026 - 2031)",
      "value": 16.07,
      "unitText": "PERCENT"
    },
    {
      "@type": "PropertyValue",
      "name": "Fastest Growing Market",
      "value": "Asia Pacific"
    },
    {
      "@type": "PropertyValue",
      "name": "Largest Market",
      "value": "North America"
    },
    {
      "@type": "PropertyValue",
      "name": "Market Concentration",
      "value": "Medium"
    }
  ],
  "faq": [
    {
      "@type": "Question",
      "name": "What is the current size of the cancer monoclonal antibodies market?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The market reaches USD 107.82 billion in 2026 and is projected to rise to USD 227.16 billion by 2031 at a 16.07% CAGR."
      }
    },
    {
      "@type": "Question",
      "name": "Which geographic region is growing the fastest?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Asia-Pacific posts the highest 18.92% CAGR through 2031, driven by China's large clinical-trial pipeline and expanding manufacturing capacity."
      }
    },
    {
      "@type": "Question",
      "name": "Which antibody source segment leads, and which is expanding the quickest?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Humanized antibodies hold 50.62% revenue share, while fully-human antibodies grow the fastest at 18.59% CAGR thanks to lower immunogenicity and broader combination use."
      }
    },
    {
      "@type": "Question",
      "name": "What are the top drivers behind market growth?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Key growth factors include rising global cancer incidence, increased oncology R&D budgets, adoption of bispecific antibodies and antibody-drug conjugates, and AI-enabled antibody engineering."
      }
    },
    {
      "@type": "Question",
      "name": "How are distribution channels evolving?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Hospital pharmacies remain dominant with 52.24% share, but online pharmacies record an 17.95% CAGR because subcutaneous formulations support home administration."
      }
    },
    {
      "@type": "Question",
      "name": "What major challenges could slow adoption?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Stringent regulatory reviews, bioreactor and raw-material shortages, and competition from CAR-T and gene-editing therapies can temper the otherwise strong growth trajectory."
      }
    }
  ],
  "images": [
    "images/cancer-monoclonal-antibodies-market-size-image-1775125216443.png",
    "images/cancer-monoclonal-antibodies-market_cancer_players.png",
    "images/cancer-monoclonal-antibodies-market-Cancer-Monoclonal-Antibodies-Market-Market-Share-by-Source-of-Antibody-2025-1768460476595.png",
    "images/cancer-monoclonal-antibodies-market-Cancer-Monoclonal-Antibodies-Market-Market-Share-by-Cancer-Application-2025-1768460480895.png",
    "images/cancer-monoclonal-antibodies-market-Cancer-Monoclonal-Antibodies-Market-CAGR--Growth-Rate-by-Region-2026---2031-1768460485214.png",
    "images/cancer-monoclonal-antibodies-market-competitive-landscape-1750335294005.png",
    "images/market-snapshot.png",
    "images/pdf3.png",
    "images/Esomar-25.png",
    "images/GPTW-25-3xl.png",
    "images/cancer-monoclonal-antibodies-market-size-image-1775125216443.png"
  ],
  "sections_count": 11
}